DCG066 is an inhibitor of the lysine methyltransferase G9a; it directly binds to G9a and inhibits its methyltransferase activity in vitro; it reduces histone H3 lysine 9 dimethylation (H3K9Me2) levels, suppresses cell proliferation, and induces apoptosis; it exhibits low cytotoxicity in G9a-overexpressing leukemia cell lines, including K562.